CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX was delisted on the 11th of July, 2016.
21 hedge funds and large institutions have $7.81M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
49% more capital invested
Capital invested by funds: $5.23M → $7.81M (+$2.58M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
5% more funds holding
Funds holding: 20 → 21 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$1.05M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$579K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$199K |
| 4 |
HF
Hoxton Financial
Shepherdstown,
West Virginia
|
+$82.2K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$69.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$58K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$27K |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$21K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$5.21K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| – | -$1K | -500 | Closed |
|
CPXX Hedge Fund Activity: Q4 2015 in Review
21 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q4 2015, worth a combined $7.81M — up 49% from $5.23M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CPXX positions and 6 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.
The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $1.05M. The largest seller was Goldman Sachs, exiting entirely with an estimated $58K sold.
- 21 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q4 2015, up from 20 in Q3 2015.
- Funds reported $7.81M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q4 2015, up 49% quarter-over-quarter.
- 7 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q4 2015 and 6 closed out, a net change of +1 holder.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q4 2015 was First Eagle Investment Management, an estimated $1.05M added.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q4 2015 was Goldman Sachs, an estimated $58K sold.
Based on aggregated 13F filings for Q4 2015.